ASXL1 Mutations Predict Inferior Molecular Response to Nilotinib Treatment in Chronic Myeloid Leukemia.

Lioba Schönfeld,Jenny Rinke,Anna Hinze,Saskia N. Nagel,Vivien Schäfer,Thomas Schenk,Christian Fabisch,Tim H. Brümmendorf,Andreas Burchert,Philipp le Coutre,Stefan W. Krause,Susanne Saussele,Fatemeh Safizadeh,Markus Pfirrmann,Andreas Hochhaus,Thomas Ernst

Leukemia（2022）

引用 12|浏览14

暂无评分

关键词

Cancer genomics,Chronic myeloid leukaemia,Medicine/Public Health,general,Internal Medicine,Intensive / Critical Care Medicine,Cancer Research,Oncology,Hematology

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要